Provectus Biopharmaceuticals, Inc.

PVCT·OTC·$0.07Share Price as of 11/2·$27MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/13/26 10-QQ1 ended 03/31/2605/14/26 10-KFY 202503/26/26 10-QQ3 ended 09/30/2511/13/25 10-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report07/01/26 8-KCurrent report06/22/26 8-KCurrent report06/18/26 8-KCurrent report04/21/26 8-KCurrent report02/02/26

Prospectuses and Registrations

424B3Prospectus03/06/17 424B3Prospectus02/21/17 424B3Prospectus02/09/17 424B4Prospectus01/31/17 S-1/ARegistration statement (amended)01/26/17

Proxies

DEF 14ADefinitive proxy04/30/26 DEFA14AAdditional proxy materials04/30/26 PRE 14APreliminary proxy04/20/26 DEFA14AAdditional proxy materials06/18/25 DEF 14ADefinitive proxy05/01/25

Ownership

Form 4Insider transaction10/30/26 Form 4Insider transaction10/23/26 Form 4Insider transaction10/13/26 Form 4Insider transaction10/05/26 Form 4Insider transaction09/18/26

Other

ARSAnnual report to shareholders04/30/26 ARSAnnual report to shareholders05/05/25 DD07/17/24 ARSAnnual report to shareholders05/09/24 ARSAnnual report to shareholders05/11/23